实用医学杂志 ›› 2023, Vol. 39 ›› Issue (20): 2683-2686.doi: 10.3969/j.issn.1006-5725.2023.20.022

• 综述 • 上一篇    下一篇

IL-18和IL-37b对naïve CD4+ T细胞分化的影响及其在哮喘中的作用研究进展

王君灵1,2,湛萌萌1,谷芳秋2,张钊龙1,王思勤1(),何韶衡2   

  1. 1.郑州大学人民医院、河南省人民医院过敏反应科 (郑州 450003 )
    2.锦州医科大学附属第一医院变态反应与;临床免疫研究中心 (辽宁 锦州 121001 )
  • 收稿日期:2023-07-10 出版日期:2023-10-25 发布日期:2023-11-15
  • 通讯作者: 王思勤 E-mail:wangsiqin273@126.com
  • 基金资助:
    国家自然科学基金项目(81471592);河南省重点研发与推广专项(232102311022);博士后科研启动基金项目(HN2022097);辽宁省自然科学基金项目(2019-ZD-0801);锦州医科大学博泽青年科技人才托举基金项目(JYBZQT2110)

Research progress of IL⁃18 and IL⁃37b in naïve CD4+ T differentiation of patients with allergic asthma

Junling WANG1,2,Mengmeng ZHAN1,Fangqiu GU2,Zhaolong ZHANG1,Siqin WANG1(),Shaoheng. HE2   

  1. 1.Department of Allergy,Henan Provincial People's Hospital,Zhengzhou University People's Hospital,Zhengzhou 450003,China
    2.Allergy and Clinical Immunology Research Centre, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China
  • Received:2023-07-10 Online:2023-10-25 Published:2023-11-15
  • Contact: Siqin WANG E-mail:wangsiqin273@126.com

摘要:

过敏性哮喘(allergic asthma,AA)是呼吸系统最常见的过敏性疾病之一,CD4+ T细胞相关亚型在AA发病中起重要作用。白细胞介素(IL)-18和IL-37b通过与IL-18Rα结合调控na?ve CD4+ T细胞的分化进而在AA中起拮抗作用。鉴于此,了解IL-18和IL-37b在AA na?ve CD4+ T细胞分化中的作用对于AA的病机、诊疗及其相关生物制剂的研发具有重要意义。

关键词: 过敏性哮喘, na?ve CD4+ T细胞, 白细胞介素-18, 白细胞介素-37b

Abstract:

Allergic asthma (AA) is one of the most common allergic respiratory diseases. CD4+ T cell subtypes play an important role in the pathogenesis of AA. IL-18 and IL-37b are involved in the pathogenesis of AA via binding to IL-18Rα and thus regulating the differentiation of na?ve CD4+ T cells. In view of this, understanding the role of IL-18 and IL-37b in the differentiation of na?ve CD4+ T cells in AA is of great significance for the pathogenesis, diagnosis and treatment of AA, and for the research and development of biological agents.

Key words: allergic asthma, na?ve CD4+ T cell, interleukin-18, interleukin-37b

中图分类号: